These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30661641)

  • 41. Implementation of medication review with follow-up in a Spanish community pharmacy and its achieved outcomes.
    Ocampo CC; Garcia-Cardenas V; Martinez-Martinez F; Benrimoj SI; Amariles P; Gastelurrutia MA
    Int J Clin Pharm; 2015 Oct; 37(5):931-40. PubMed ID: 26040837
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Unit cost of common illness management: a comparison between a primary care unit and a community pharmacy in Thailand.
    Saramunee K; Ploylearmsang C; Chaiyasong S; Phimarn W; Sookaneknun P
    Prim Health Care Res Dev; 2017 Jul; 18(4):376-385. PubMed ID: 28414006
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Advancing the role of the pharmacy technician: A systematic review.
    Mattingly AN; Mattingly TJ
    J Am Pharm Assoc (2003); 2018; 58(1):94-108. PubMed ID: 29198648
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacist views and pharmacy capacity to deliver professional services in the United Arab Emirates.
    Alzubaidi H; Saidawi W; Mc Namara K
    Int J Clin Pharm; 2018 Oct; 40(5):1106-1115. PubMed ID: 29926256
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effectiveness of implementation strategies for clinical guidelines to community pharmacy: a systematic review.
    Watkins K; Wood H; Schneider CR; Clifford R
    Implement Sci; 2015 Oct; 10():151. PubMed ID: 26514874
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of pharmacy technicians in elements of medication therapy management delivery: A systematic review.
    Gernant SA; Nguyen MO; Siddiqui S; Schneller M
    Res Social Adm Pharm; 2018 Oct; 14(10):883-890. PubMed ID: 29221929
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Healthcare professional-patient relationships: Systematic review of theoretical models from a community pharmacy perspective.
    Sabater-Galindo M; Fernandez-Llimos F; Sabater-Hernández D; Martínez-Martínez F; Benrimoj SI
    Patient Educ Couns; 2016 Mar; 99(3):339-347. PubMed ID: 26475728
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A systematic review of pharmacists performing obstructive sleep apnea screening services.
    Cawley MJ; Warning WJ
    Int J Clin Pharm; 2016 Aug; 38(4):752-60. PubMed ID: 27241341
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence of the economic benefit of clinical pharmacy services: 1996-2000.
    Schumock GT; Butler MG; Meek PD; Vermeulen LC; Arondekar BV; Bauman JL;
    Pharmacotherapy; 2003 Jan; 23(1):113-32. PubMed ID: 12523470
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Culture in community pharmacy organisations: what can we glean from the literature?
    Jacobs S; Ashcroft D; Hassell K
    J Health Organ Manag; 2011; 25(4):420-54. PubMed ID: 22039661
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Community osteoporosis screening services for the prevention of osteoporotic fractures in population health: a literature review.
    Nguyen VH
    Int J Evid Based Healthc; 2017 Jun; 15(2):43-52. PubMed ID: 28448327
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The feasibility of providing community pharmacy-based services for alcohol misuse: a literature review.
    Watson MC; Blenkinsopp A
    Int J Pharm Pract; 2009 Aug; 17(4):199-205. PubMed ID: 20217944
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of pharmacists providing a prescription review and monitoring service in ambulatory care or community practice.
    Tully MP; Seston EM
    Ann Pharmacother; 2000 Nov; 34(11):1320-31. PubMed ID: 11098348
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy.
    Gubbins PO; Klepser ME; Dering-Anderson AM; Bauer KA; Darin KM; Klepser S; Matthias KR; Scarsi K
    J Am Pharm Assoc (2003); 2014; 54(2):163-71. PubMed ID: 24632931
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of Medicare Part D on independent and chain community pharmacies in rural Illinois--A qualitative study.
    Bono JD; Crawford SY
    Res Social Adm Pharm; 2010 Jun; 6(2):110-20. PubMed ID: 20511110
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A structured patient identification model for medication therapy management services in a community pharmacy.
    Pagano GM; Groves BK; Kuhn CH; Porter K; Mehta BH
    J Am Pharm Assoc (2003); 2017; 57(5):619-623.e1. PubMed ID: 28733156
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluating the economic impact of a targeted medication intervention program.
    Rhodes SA; Reynolds AE; Marciniak MW; Ferreri SP
    J Pharm Pract; 2013 Dec; 26(6):562-73. PubMed ID: 23804242
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Can clinical pharmacy services have a positive impact on drug-related problems and health outcomes in community-based older adults?
    Hanlon JT; Lindblad CI; Gray SL
    Am J Geriatr Pharmacother; 2004 Mar; 2(1):3-13. PubMed ID: 15555474
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of pharmacists' interventions in asthma management: A systematic review.
    Crespo-Gonzalez C; Fernandez-Llimos F; Rotta I; Correr CJ; Benrimoj SI; Garcia-Cardenas V
    J Am Pharm Assoc (2003); 2018; 58(2):210-219. PubMed ID: 29439927
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Financial Viability of Emergency Department Observation Unit Billing Models.
    Baugh CW; Suri P; Caspers CG; Granovsky MA; Neal K; Ross MA
    Acad Emerg Med; 2019 Jan; 26(1):31-40. PubMed ID: 29768698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.